05th week of 2011 patent applcation highlights part 50 |
Patent application number | Title | Published |
20110028516 | STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS - Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein. | 2011-02-03 |
20110028517 | 4-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXAMIDE USEFUL AS A CANNABINOID CB1 NEUTRAL ANTAGONIST - The present invention relates to 4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide, and pharmaceutically acceptable salts and solvates thereof. It further concerns pharmaceutical compositions comprising this compound as active ingredient as well as processes and intermediates for preparing this compound and compositions. The referred compound is a cannabinoid CB1 neutral antagonist useful in the prophylaxis and treatment of food intake disorders. | 2011-02-03 |
20110028518 | DEXLANSOPRAZOLE PROCESS AND POLYMORPHS - Processes for the preparation of dexlansoprazole, an amorphous form of dexlansoprazole, a solid dispersion of amorphous dexlansoprazole and a pharmaceutically acceptable carrier, and processes for their preparation. Also provided are crystalline compounds 2-[(R)-[(4-chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole and 2-[(R)-[(4-nitro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, and methods for their preparation. | 2011-02-03 |
20110028519 | SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES - Compounds of Formula I are described | 2011-02-03 |
20110028520 | 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS - CB-1 receptor inverse agonist compounds of Formula and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia. | 2011-02-03 |
20110028521 | PESTICIDAL COMPOSITION, AND METHOD FOR CONTROLLING PESTS - To provide a pesticidal composition having a stable and high pesticidal effect. The pesticidal composition comprises a pyridine compound represented by the formula (I): | 2011-02-03 |
20110028522 | FULLERENE THERAPIES FOR INFLAMMATION - Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene. | 2011-02-03 |
20110028523 | Selective Alpha 2B/2C Agonists - Described herein are compounds useful as agonists of alpha 2B/2C receptors. Pharmaceutical compositions including the presently described compounds and methods of treatment of diseases and conditions with the presently described compounds also are disclosed. | 2011-02-03 |
20110028524 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 2011-02-03 |
20110028525 | Synergistic Microbicidal Compositions - This invention relates to synergistic combinations of selected isothiazolin-3-one microbicides in combination with a second microbicide or formulation ingredient or raw material. The combinations have greater efficacy than would be expected from combinations of the individual components. The combinations include mixtures of (a) Methyl-4-isothiazolin-3-one or (b) 1,2-Benzisothiazolin-3-one with one or more of a variety of other compounds. | 2011-02-03 |
20110028526 | VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS - The invention relates to melt granulation processes for preparing immediate release and sustained release pharmaceutical formulations comprising valsartan. | 2011-02-03 |
20110028527 | Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma - Embodiments of the invention relate to the treatment of neuropathic pain in mammals. Embodiments of the invention include methods for treating neuropathic pain with benzimidazole derivatives with PPARgamma agonist activity, as well as methods for preparing medicaments used in such treatments of mammalian pain. | 2011-02-03 |
20110028528 | PESTICIDAL AQUEOUS SUSPENSION COMPOSITION - When an organosilicone surface active agent is added to a pesticidal aqueous suspension composition containing an active ingredient compound of a sparingly water-soluble pesticide for the purpose of attaining activity enhancement and formulation, the following problems arise: such that (1) the viscosity of the composition increases; (2) a large amount of foams due to the organosilicone surface active agent tends to generate at the time of preparation of a spray solution; and the like. Thus, measuring the composition and preparation of a spray solution were difficult. The present invention provides a pesticidal aqueous suspension composition including (a) an active ingredient compound of a sparingly water-soluble pesticide, (b) an organosilicone surface active agent, (c) a viscosity-reducing agent, (d) an antifoaming agent, (e) a pH adjustor and (f) a dispersant, which is suppressed in increasing in the viscosity, is easy to measure, hardly generates foams at the time of dilution with water and is easy to prepare a spray solution. | 2011-02-03 |
20110028529 | NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471 - New crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described. | 2011-02-03 |
20110028530 | NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471 - New crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described. | 2011-02-03 |
20110028531 | NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801 - The present invention provides chemically modified siRNA compounds that target RTP801 and pharmaceutical compositions comprising same useful for treating microvascular disorders, eye diseases, hearing impairment, neurodegenerative diseases and disorders, spinal cord injury and respiratory conditions. | 2011-02-03 |
20110028532 | Methods of treating eye diseases in diabetic patients - The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein. | 2011-02-03 |
20110028533 | NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE - Provided is a novel Fer-like protein, referred to as “FerC” (Fer colorectal cancer). FerC is a 47kDa protein having a unique N-terminal sequence and was found to be present in six colon cancer cell-lines and in five hepatocarcinoma (liver cancer) cell-lines, but not in CCD33 normal colon epithelial cells or normal human and mouse fibroblasts. Depletion of FerC impairs cell-cycle progression and induces apoptotic death in treated colon cancer (CC) cells. Also provided are nucleotide sequences that are antisense to at least a portion of the N-terminal sequence, short interfering nucleotides including such an antisense sequence, as well as pharmaceutical compositions containing an antisense sequence. The present pharmaceutical composition may be used in the treatment of cancer, in particular, colorectal cancer and liver cancer. | 2011-02-03 |
20110028534 | RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS - RNA interference is provided for inhibition of connective tissue growth factor mRNA expression in ocular disorders involving CTGF expression. Ocular disorders involving aberrant CTGF expression include glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing. Such disorders are treated by administering interfering RNAs of the present invention. | 2011-02-03 |
20110028535 | OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS - Preparations for transferring efficiently oligonucleotides necessary in antisense therapy or the like into animal cells so as to be useful in treatment for various diseases, which comprises a collagen as an essential component are provided. | 2011-02-03 |
20110028536 | METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION - Disclosed herein are methods and compositions for enhancing the sensitivity of cells to the effects of topoisomerase I inhibitors. Also disclosed are methods and compositions for inducing apoptosis and/or growth arrest which may be used for tumor suppression. | 2011-02-03 |
20110028537 | SOMATIC CELL REPROGRAMMING - The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method. | 2011-02-03 |
20110028538 | METHODS AND COMPOSITIONS RELATED TO TR4 LIGAND - Disclosed are compositions and methods related to TR4 and aging. | 2011-02-03 |
20110028539 | Biologically active taxane analogs and methods of treatment - The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: | 2011-02-03 |
20110028540 | SYNTHESIS OF MACROCYCLIC CANCER CHEMOTHERAPY AGENTS AND METHODS OF USE - Herein are described a process for forming a quaternary carbon useful in the preparation of macrolactones, an enantioselective synthesis of (+)-peloruside A, and methods for treating a patient in need of relief from cancer or a cancer-related disease. The described processes are useful for preparing compounds containing quaternary carbons, including structural analogs and derivatives of peloruside A. | 2011-02-03 |
20110028541 | LUBIPROSTONE CRYSTAL, THE USE AND THE METHOD FOR THE PREPARATION THEREOF - The present invention relates to a lubiprostone crystal, the method for the preparation thereof, and a pharmaceutical composition or kit comprising the same, as well as the use of said crystal in the preparation of a medicament for the treatment of gastrointestinal tract diseases, especially constipation. The X-ray powder diffraction pattern of said crystal comprises characteristic peaks measured at the following 2θ reflection angles: 14.6±0.2°, 17.0±0.2° and 19.6±0.2°. As compared to amorphous lubiprostone, the crystal of the present invention has the advantages of relative high purity, stable properties and easy-for-storage and use. | 2011-02-03 |
20110028542 | COMPOSITIONS FOR PREVENTION OR TREATMENT OF ANOREXIA-CACHEXIA SYNDROME AND USES THEREOF - A pharmaceutical composition for 1) increasing weight gain; and/or 2) decreasing weight loss; and/or 3) increasing appetite in a subject in need thereof, comprising purified β-caryophyllene together with a pharmaceutically acceptable carrier. Also provided are pharmaceutical compositions for use in the prevention or treatment of Anorexia-Cachexia Syndrome, the pharmaceutical composition comprising purified β-caryophyllene together with a pharmaceutically acceptable carrier. | 2011-02-03 |
20110028543 | Formulations and methods of using nitric oxide mimetics in cancer treatment - The present invention relates to methods and formulations for inhibiting, treating and preventing a malignant cell phenotype, cell, tumor and/or disease. Administration of nitric oxide mimetics, such as low doses, is sufficient to increase, restore or maintain nitric oxide-mediated signaling in cells so that malignant cell phenotypes, cells, tumors and/or diseases are inhibited or prevented. These methods and formulations are particularly useful in treating and preventing cancer in animals. | 2011-02-03 |
20110028544 | CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE - Catechol protected levodopa diester prodrugs pharmaceutical, compositions comprising catechol protected levodopa diester prodrugs, and methods of using such prodrugs and pharmaceutical compositions for treating diseases such as Parkinson's disease are provided. | 2011-02-03 |
20110028545 | PROCESS FOR INCORPORATING ANTIMICROBIAL PRODUCTS INTO SOAP COMPOSITIONS - The present invention relates to a process for producing concentrates of antimicrobial active ingredients, the concentrates themselves and their use for producing solid, liquid or pasty body cleaning compositions, such as in particular soaps. | 2011-02-03 |
20110028546 | NOVEL ANTIMICROBIAL FORMULATIONS INCORPORATING ALKYL ESTERS OF FATTY ACIDS AND NANOEMULSIONS THEREOF - The present invention relates to a novel antimicrobial composition and method comprising any of the C1-C4 monohydric alcohol esters of C8 to C22 fatty acids, and most preferably the C1-C4 monohydric alcohol esters of C8 to C12 fatty acids, namely, caprylic, capric, and lauric fatty acids. Specifically the invention is related to a composition and method to disinfect various surfaces and substrates including the surfaces of food products, animal and human tissue and appendages, inanimate objects of various compositions, and also enclosed spaces. The invention can be incorporated into various media including liquids, gels, powders, paints, sealants, and the like and can be in the form of emulsions including nanoemulsions. | 2011-02-03 |
20110028547 | NOVEL USE OF CAPSIATE OR DIHYDROCAPSIDATE - The present invention relates to a new use of capsiate or dihydrocapsiate, more particularly to a composition for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease or for suppressing immunity comprising capsiate, dihydrocapsiate or a pharmaceutically acceptable salt thereof as an effective ingredient. The composition and immunosuppressant of the present invention may be used for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease, and for suppressing immunity. | 2011-02-03 |
20110028548 | BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW - The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the transdermal delivery of the nitric oxide precursor L-arginine and/or its derivatives alone, or optionally in conjunction with an adjunct such as theophylline. The transdermal delivery is effected, in certain embodiments through the means of a hostile biophysical environment, such as that created by a high ionic strength environment. Various pathological states caused by, or occurring in conjunction with, insufficient blood flow, can be treated using the systems and methods of the invention as described herein. In other embodiments, increased blood flow using the systems and methods of the invention may result in enhanced healing, for example, through greater availability of the constituents of the blood. Examples of conditions which may benefit from increased blood flow include, but are not limited to, erectile dysfunction, hair loss, female sexual dissatisfaction, sagging facial or other body tissue, peripheral vascular disease including claudication, neuropathy, skin ulcers, bone healing, wound healing, viral and bacterial infection, and skin grafting. | 2011-02-03 |
20110028549 | USE OF A MONOTERPENE TO TREAT OR PREVENT STRESS - The present invention relates to the use of a monoterpene for the prevention, alleviation or treatment of a pathological or non-pathological stress condition of an individual. | 2011-02-03 |
20110028550 | COMPOSITIONS AND METHODS FOR CONTROL OF LISTERIA MONOCYTOGENES - The present invention relates to methods for inhibiting the growth of pathogenic microbes in food products. In an embodiment the invention is a preservative composition including lactic acid or a salt thereof, acetic acid or a salt thereof, and propionic acid or a salt thereof. In an embodiment, the invention is a food product including lactic acid or a salt thereof, acetic acid or a salt thereof, and propionic acid or a salt thereof. In an embodiment, the invention includes a method of making a food product including adding an antimicrobial preservative composition to a composition comprising a meat, the antimicrobial preservative composition comprising lactic acid or a salt thereof, propionic acid or a salt thereof, and acetic acid or a salt thereof. Other embodiments are also included herein. | 2011-02-03 |
20110028551 | NOVEL PROCESS FOR THE PREPARATION OF SODIUM GAMMA-HYDROXYBUTYRATE - The present invention is directed to a process for the preparation of the saponification products of lactones, preferably three- to eight-membered lactones. The present invention is also directed to a process for the preparation of compounds having general formula (I): wherein M is selected from the group consisting of cationic species, preferably metal cations (even more preferably Na), from a compound having the formula (II): comprising reacting a compound having formula (II) with a suitable hydroxide salt (M-OH) (III) such as, preferably, sodium hydroxide, in an aqueous medium. The reaction preferably utilizes a continuous process method for the substantial consumption of reagent and continuous, semi-continuous, and/or batch-wise processing for final consumption of reagent. | 2011-02-03 |
20110028552 | MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF - The present invention concerns prodrugs of mexiletine (and mexiletine's active metabolite) with amino acids or peptides and pharmaceutical compositions containing such prodrugs. Methods for providing pain relief, treating arrhythmia, decreasing the adverse GI side effects associated with mexiletine, increasing the bioavailability of mexiletine, and improving the pharmacokinetic reproducibility of mexiletine with the aforementioned prodrugs are also provided. Oligopeptides incorporating lysine or arginine residues attached directly or indirectly through a glycine residue are also described herein. | 2011-02-03 |
20110028553 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN - Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated. | 2011-02-03 |
20110028554 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE - The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3′,3-diiodothyronine (3′,3-T2), 3′,5-diiodothyronine (3′,5-T2), 3′-iodothyronine (3′-T), 3-iodothyronine (3-T) or 5-iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle. | 2011-02-03 |
20110028555 | Antiinflammatory and Analgesic Preparation for External Use - It is intended to provide an antiinflammatory and analgesic preparation for external use whereby side effects of a nonsteroidal antiinflammatory and analgesic drug on the skin can be regulated, the nonsteroidal antiinflammatory and analgesic drug can be prevented from degeneration with time due to a dibenzoylmethane derivative contained as an UV absorbent therein, the dibenzoylmethane derivative can be prevented from crystallization and sedimentation due to an oily phase component contained therein, and the inherent effects of the nonsteroidal anti-inflammatory and analgesic drug can be fully exerted without showing skin irritation caused by the oily phase component, an emulsifier and a thickener. The above problem can be solved by providing an antiinflammatory and analgesic preparation for external use which comprises a base for external use containing an oily phase component, a nonsteroidal antiinflammatory and analgesic drug and a dibenzoylmethane derivative and in which the total amount of fatty acid esters in the oily phase component is at least thrice as much as the content of the dibenzoylmethane derivative. | 2011-02-03 |
20110028556 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN - Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated. | 2011-02-03 |
20110028557 | TREATING PATIENTS WITH INTRAVENOUS IBUPROFEN - Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure. | 2011-02-03 |
20110028558 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN - Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated. | 2011-02-03 |
20110028559 | SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS - Treating pain in mammals with a compound having the formula (I) is disclosed herein. | 2011-02-03 |
20110028560 | SELF-EMULSIFIABLE LIQUID FLORFENICOL COMPOSITION INTENDED TO BE INCORPORATED INTO THE DRINKING WATER OF LIVESTOCK - The invention relates to a self-emulsifiable liquid composition intended to be diluted in an aqueous intermediate solution and then incorporated into the drinking water of livestock animals, and also to the use of such a composition. The invention is characterized in that the composition comprises at least—between 1% and 12% by weight of the florfenicol active ingredient, relative to the total volume of the composition; —at least 50% by weight, relative to the total volume of the composition (p/v), of a mixture of C8-C10 saturated polyglycosylated glycerides having an HLB (hydrophilic-lipophilic balance) of less than 16; and—at least 5% by weight, relative to the total volume of the composition (p/v), of a surfactant. | 2011-02-03 |
20110028561 | PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM - Described herein are methods for treatment or prevention of retinal dysfuntion by reduction of rod cell energy demand. Particular embodiments include methods for improving rod-mediated retinal function in a developing retina by administering an agent that reduces energy demand in the rod cell. Such agents that target rod cell energy demand can be administered to a subject at risk for retinal dysfunction to modify rod-cell function, such that the retina reaches retinal maturity. Also described herein are methods for suppressing the visual cycle in a developing rod cell by contacting the cell with an agent that reduces the energy demand of the rod cell. | 2011-02-03 |
20110028562 | DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE - The subject of the invention is a group of new derivatives of aminoalkaπols, more specifically [(phenoxy)alkyl]aminoalkanols and [(phenoxy)acyl)aminoalkanols, their method of obtaining and their use for production of a medicine which is used in the prophylaxis, prevention and/or treatment of diseases or symptoms having neurological background and for production of a medicine with anticonvulsant activity, which is used in seizures of various origin, also in the limbic system, in myoclonic or sound-induced seizures, in psychomotor epilepsy, as well as in relieving neuropathic or inflammatory pain. | 2011-02-03 |
20110028563 | ANTI-MICROBIAL COMPOSITION - The present invention relates to an anti-microbial composition and method of use thereof. In particular, the present invention relates to an anti microbial composition comprising farnesol and cetrimide. | 2011-02-03 |
20110028564 | COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES - The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal. | 2011-02-03 |
20110028565 | EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT - A pharmaceutical composition includes a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of exo-R-mecamylamine in combination with a pharmaceutically acceptable carrier. Preferably the amount is about 0.5 mg to about 20 mg. Medical conditions are treated by administering a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of its exo-R-mecamylamine, said amount being sufficient to ameliorate the medical condition. The medical conditions include but are not limited to substance addiction (involving nicotine, cocaine, alcohol, amphetamine, opiate, other psychostimulant and a combination thereof), aiding smoking cessation, treating weight gain associated with smoking cessation, hypertension, hypertensive crisis, Tourette's Syndrome and other tremors, cancer (such as small cell lung cancer), atherogenic profile, neuropsychiatric disorders (such as bipolar disorder, depression, an anxiety disorder, schizophrenia, a seizure disorder, Parkinson's disease and attention deficit hyperactivity disorder), chronic fatigue syndrome, Crohn's disease, autonomic dysreflexia, and spasmogenic intestinal disorders. | 2011-02-03 |
20110028566 | COMPOSITIONS AND PRODUCTS CONTAINING CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS AND METHODS OF USING THE COMPOSITIONS AND PRODUCTS - Compositions comprising at least one cycloaliphatic diol antimicrobial agent and at least one other antimicrobial agent and methods of making and using these compositions are provided. The cycloaliphatic diol antimicrobial agents comprise 1,1-cyclohexanedimethanol, 1,2-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, 2,2,4,4-tetramethyl-1,3-cyclobutanediol, or mixtures thereof. | 2011-02-03 |
20110028567 | SMOOTH MUSCLE CONTRACTION INHIBITORS - An emulsion comprising L-Menthol, a fat or oil and a surfactant wherein oil particles have an average diameter of 100 nm or less inhibits a content reduction attributed to, for example, evaporation of L-menthol, enhances a light transmission through liquid and is stable despite long-term storage. Thus, the emulsion can be appropriately used in the temporary inhibition of contraction of gastrointestinal tract for, for example, observation of gastrointestinal tract by an endoscope. This emulsion can be obtained by heating an oil-in-water type emulsion comprising L-menthol, a fat or oil and a surfactant at 60° C. or higher. | 2011-02-03 |
20110028568 | PREPARATION FOR MAGNESIUM AMMONIUM PHOSPHATE CEMENTS - The invention relates to a preparation for a magnesium ammonium phosphate cement. There is provided a preparation comprising (a) a magnesium calcium phosphate of the formula Mg | 2011-02-03 |
20110028569 | MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS - The present invention provides for a mixture comprising a siloxane having the formula: M | 2011-02-03 |
20110028570 | SELF EMULSIFYING GRANULES AND PROCESS FOR THE PREPARATION OF EMULSIONS THEREFROM - A process for making a self-emulsifying granule suitable for use in forming latex emulsions includes contacting a resin with a solid or highly concentrated surfactant, a solid neutralization agent and water in the absence of an organic solvent to form a mixture, melt mixing the mixture, and forming self-emulsifying granules of the melt mixed mixture. Self-emulsifying granules are also provided and configured to form a latex emulsion when added to water. | 2011-02-03 |
20110028571 | SILICONE-MODIFIED WAX-CONTAINING COMPOSITION AND COSMETIC PREPARATION CONTAINING THE COMPOSITION - A composition for cosmetic preparation and a cosmetic preparation including the composition are provided. The composition includes a silicone-modified wax having a melting point of 100° C. or above and an unctuous agent having a melting point of 80° C. or below. The composition is prepared by cooling after dissolving and mixing the silicone-modified wax and the unctuous agent at temperature equal to or higher than the melting point of the silicone-modified wax. The composition has a smooth feel and a glossy surface and can be blended in a cosmetic preparation without being heated at 100° C. or above. | 2011-02-03 |
20110028572 | PRODUCT FOR TREATING A TOILET FLUSH CISTERN AND BOWL - The present invention relates to a liquid additive product including at least one acid, intended, in combination with the water contained in a toilet flush cistern of a WC, to constitute an agent for treating polluting elements contained in the cistern, characterized in that the viscosity of the additive product is less than 500 mPa·s; wherein this acid is an organic acid, the concentration of which is at least equal to 30% by weight. It also relates to a treating agent consisting of the additive product and the water contained in the cistern; wherein the concentration of this additive product, in the water of the cistern, is between 100 ppm and 1000 ppm. | 2011-02-03 |
20110028573 | High Shear Production of Value-Added Product From Refinery-Related Gas - A method of producing value-added product from refinery-related gas, the method comprising: providing a refinery-related gas comprising at least one selected from C1-C8 compounds; intimately mixing the refinery-related gas with a liquid carrier in a high shear device to form a dispersion of gas in the liquid carrier, wherein the gas bubbles in the dispersion have a mean diameter of less than or equal to about 5 μm; and extracting value-added product comprising at least one component selected from higher hydrocarbons, olefins and alcohols. A system for producing value-added product from refinery-related gas comprising: at least one high shear device comprising at least one rotor and at least one complementarily-shaped stator; apparatus for the production of a refinery-related gas comprising one or more of C1-C8 compounds; and a pump configured for delivering a liquid stream comprising the liquid carrier to the high shear device. | 2011-02-03 |
20110028574 | Method and Apparatus for the Continuous Separation and Discharge of Solid Catalysts and Products for Fischer-Tropsch Synthesis Reactions - The present invention relates to a continuous separation and discharge apparatus and method of solid catalysts and liquid products for Fischer-Tropsch synthesis reactions, and more particularly, to a continuous separation and discharge apparatus and method of solid catalysts and products for Fischer-Tropsch synthesis reactions involving the conversion of synthetic gas into synthetic oil, by which products of the Fischer-Tropsch synthesis including wax, as a long-chain hydrocarbon, can be stably obtained by continuously separating the products from a slurry comprising solid catalyst particles and the products using periodic pulses of a feeding gas and discharging the products through a lower portion of a reactor. Provided is a continuous separation and discharge apparatus of solid catalysts and products for Fischer-Tropsch synthesis reactions including: a level sensing device which is installed at an upper portion of a reactor and detects the slurry-level of reactants; a solid catalyst/product separation device and a discharge device which are installed at a lower portion of the reactor and separate and discharge liquid products from a mixed slurry in the reactor; and a control unit which receives a signal from the level sensing device to open and close the discharge device, wherein the separation device filters the solid catalysts, and the discharge device continuously discharges the products separated from the solid catalysts through the lower portion of the reactor by the amount of the synthesized products measured by a level sensing device. | 2011-02-03 |
20110028575 | Catalysts - A process for preparing a cobalt based Fischer-Tropsch synthesis catalyst precursor includes introducing a multi-functional carboxylic acid having the general formula (1) HOOC—C*R | 2011-02-03 |
20110028576 | MESOPOROUS MATERIALS AND REACTANTS FOR PREPARING THEM - The invention relates to a process for manufacturing porous materials, which comprises the following steps: preparation of a solution of at least one structuring agent, having at least two structuring parts linked by at least one type of reversible non-covalent interaction; formation of the structured or porous material; separation of the at least two parts of the structuring agent at low temperature; and recovery of at least 50% by weight of the two non-degraded structuring parts and the porous material. | 2011-02-03 |
20110028577 | POSITIVE SKEW STYRENE-ACRYLONITRILE COPOLYMER FOAM - Prepare a polymeric foam from a foamable polymer composition containing a thermoplastic polymer composition and a blowing agent wherein 75 percent or more by weight of all non-halogenated polymers in the foamable polymer composition is a styrene-acrylonitrile copolymer composition having a polymerized acrylonitrile content distribution with a positive skew in a copolymerized AN content distribution and a positive percent difference between the mean and the median copolymerized AN content distribution. | 2011-02-03 |
20110028578 | SILOXANE COMPOSITIONS - The invention relates to siloxane compositions containing a mixing component that is based on cashew nut shell liquid—CNSL. | 2011-02-03 |
20110028579 | PROCESS FOR LIGHTENING THE COLOR OF POLYISOCYANATES WITH OZONE-CONTAINING GAS - The continuous or quasi-continuous process for lightening organic polyisocyanates with ozone-containing gas, the treatment of the organic polyisocyanate being effected with an ozone-containing gas which furthermore comprises at least one further inert and/or reactive gas can be carried out, according to the invention, in a stirred tank with connected storage tank, in a sieve tray column or in a packed column. | 2011-02-03 |
20110028580 | CARPET BACKING COMPOSITIONS - The present disclosure provides embodiments of aqueous compositions comprising a dispersed polymer for preparing a carpet backing, methods for producing a carpet product, and methods for preparing a polymer-backed carpet. The aqueous composition can be prepared by polymerizing monomers including at least 50 percent by weight of at least one compound selected from the group consisting of alkyl acrylates and alkyl methacrylates having at least 4 carbon atoms in the alkyl. at least 30 percent by weight of at least one compound selected from the group consisting of styrene and alkyl acrylates and alkyl methacrylates having not more than 3 carbon atoms in the alkyl, less than 3 percent by weight of a hydroxyalkyl acrylate, and a copolymerizable acid in an amount up to 5 percent by weight. | 2011-02-03 |
20110028581 | AROMATIC POLYESTERPOLYOLS, ISOCYANURATE-MODIFIED POLYURETHANE FOAMS, AND METHODS OF MAKING THEM - Embodiments of this disclosure include, among others, polyol mixtures, methods of making a polyol mixture, methods of making a rigid isocyanurate-modified polyurethane foam, rigid isocyanurate-modified polyurethane foams, aromatic polyesterpolyols, and the like. | 2011-02-03 |
20110028582 | HOT MELTS - The present invention relates to reactive preparations, comprising isocyanate-functional polyurethane building blocks, to a method for the production thereof, and to the use thereof as or in adhesives having high initial strength and high mechanical strength. | 2011-02-03 |
20110028583 | Adhesive Compositions for Easy Application and Improved Durability - The present invention is directed to an adhesive composition comprising a crosslinkable acrylic copolymer, a multi-functionalized crosslinkable oligomer and a photoinitiator wherein the composition exhibits excellent wet out characteristics as reflected in a tan delta value of at least 0.5, preferably greater than 0.5, more preferable greater than 0.8 as measured at 20° C. resulting from a first curing stage, and improved stiffness and temperature resistance as reflected in a storage elastic modulus of at least 300,000 Pa at 20° C. and a shear adhesion failure temperature of at least 425° F. (218.3° C.) at 1 Kg/in | 2011-02-03 |
20110028584 | CURABLE CYCLIC PHOSPHAZENE COMPOUND AND METHOD OF PREPARING THE SAME - Disclosed herein is a curable cyclic phosphazene compound having a low dielectric constant, a low dielectric loss index and high thermal stability, and a method of preparing the same. The curable cyclic phosphozene polymer prepared using the compound has a low dielectric constant and excellent thermal properties, compared to conventional phosphozene polymers. | 2011-02-03 |
20110028585 | PHOTOBASE GENERATOR - The object of the present invention is to provide a photobase generator capable of efficiently generating amines (tertiary amines and amidine) high in catalytic activity by sensing light with a wavelength of from 350 to 500 nm (especially, from 400 to 500 nm). | 2011-02-03 |
20110028586 | ENERGY RAY-CURABLE INKJET INK COMPOSITION - The present invention provides an energy ray-curable inkjet ink composition which is excellent in stretchability for a printed film and, at the same time, is excellent in curability, adherability and the continuous discharge property. The present invention relates to an energy ray-curable inkjet ink composition containing at least a coloring material, 8 to 60% by mass of a monofunctional monomer (A) having a glass transition temperature of lower than −25° C., 25 to 40% by mass of a difunctional oligomer (B) having an elongation rate of 130% or more at 25° C. when a single oligomer is polymerized, at least one kind of a photopolymerization initiator (C) selected from the group consisting of an acylphosphine oxide initiator (C-1), and a mixed initiator (C-2) of an α-aminoalkylphenone initiator and a thioxanthone initiator, and a surface tension conditioner (D). | 2011-02-03 |
20110028587 | CURABLE COMPOSITION, COLOR FILTER AND PROCESS FOR PRODUCTION THEREOF, AND SOLID-STATE IMAGING DEVICE - A curable composition containing (A) a polymerizable compound having an alkyleneoxy group having two or more carbon atoms, (B) a polymerizable compound lacking an alkyleneoxy group having two or more carbon atoms, (C) an i-line absorber, (D) a photopolymerization initiator, (E) an alkali-soluble resin, and (F) a pigment, wherein a mass ratio [(A)/((A)+(B))] is from 0.5 to 0.9, and an i-line transmittance obtainable when the curable composition is formed into a coating film having a thickness of 0.7 μm, is 10% or less. The curable composition of the invention has enhanced adhesiveness upon forming a micro pattern, and can reduce development residues in unexposed non-cured areas. The curable composition of the invention is suitable for the use in color filters. | 2011-02-03 |
20110028588 | UV-CURABLE COMPOSITION AND THE USE THEREOF AS A COATING - A UV-curable composition for coating vehicle axles includes at least one aliphatic epoxy acrylate and at least one acrylate selected from the group consisting of aromatic epoxy acrylate and polyester acrylate as a photochemically crosslinkable component; at least one reactive diluent; at least one photoinitiator; and at least one filler and/or at least one pigment. | 2011-02-03 |
20110028589 | DENTAL POLYMERIZABLE COMPOSITION AND KIT THEREFOR - The present invention provides a dental polymerizable composition which has excellent handling property by the brush-dip technique and the bulk-mix technique, particularly excellent handling property by the brush-dip technique, contains few air bubbles, is excellent in color tone, polishability, mechanical properties and the discoloration resistance of a cured product at the time of curing and is used for many purposes such as the repair of a denture base or artificial tooth, a tooth crown prosthetic restoration and a temporary prosthetic restoration which is used until a bridge is completed when it is a two-composition type self-curing resin. | 2011-02-03 |
20110028590 | ANTIMICROBIAL EFFECT OF CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS IN COATING COMPOSITIONS - A cycloaliphatic diol antimicrobial agent selected from the group consisting of 1,1-cyclohexanedimethanol, 1,2-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, and 2,2,4,4-tetramethyl-1,3-cyclobutanediol was found to provide antimicrobial activity in coating compositions and latexes, and was found to enhance the effectiveness of other antimicrobial agents commonly used in coatings and dispersions. Alone or as part of a preservative system, this cycloaliphatic diol antimicrobial agent in water can provide an easy-to-handle liquid that allows coatings producers to achieve improved microbial control, or achieve equivalent control while using less antimicrobial agents in their formulations. Consequently, the shelf life of the products can be maintained while reducing the use of the traditional preservative, or the shelf-life can be enhanced with addition of this cycloaliphatic diol antimicrobial agent to an existing antimicrobial system. | 2011-02-03 |
20110028591 | ANTIMICROBIAL NANOPARTICLES - A polymerizable composition, comprising a first component comprising a cationic nanoparticle comprising a covalently bonded ammonium group, and a second component comprising an anionic polyether compound is described. Either the first component further comprises an ethylenically unsaturated polymerizable group, the second component further comprises an ethylenically unsaturated polymerizable anion, or both. A method of making an article comprising applying the polymerizable composition to a surface of an article is also described. | 2011-02-03 |
20110028592 | ENVIRONMENTALLY DEGRADABLE COMPOSITE MATERIAL AND METHOD FOR PRODUCING THE SAME - An environmentally degradable composite having between 20 and 80 weight parts of a moderately cross-linked copolymer of aliphatic polyesteramide comprising random blocks, between 10 and 70 weight parts of a renewable raw material, between 5 and 20 weight parts of an additive, and between 0 and 30 weight parts of a filler. The composite has good mechanical properties, with a tensile strength of between 15 and 30 MPa, elongation at break of between 300 and 1000%, bending strength of between 10 and 25 MPa, and notched impact strength of between 20 and 90 kJ/m | 2011-02-03 |
20110028593 | Weighted Elastomers, Cement Compositions Comprising Weighted Elastomers, and Methods of Use - Methods and compositions are provided that relate to weighted elastomers. The weighted elastomers may comprise an elastomer and a weighting agent attached to an outer surface of the elastomer. An embodiment includes a method of cementing that comprises providing a cement composition containing cement, water, and a weighted elastomer. In addition, the cement composition may be introduced into a subterranean formation and allowed to set therein. | 2011-02-03 |
20110028594 | Weighted Elastomers, Cement Compositions Comprising Weighted Elastomers, and Methods of Use - Methods and compositions are provided that relate to weighted elastomers. The weighted elastomers may comprise an elastomer and a weighting agent attached to an outer surface of the elastomer. An embodiment includes a method of cementing that comprises providing a cement composition containing cement, water, and a weighted elastomer. In addition, the cement composition may be introduced into a subterranean formation and allowed to set therein. | 2011-02-03 |
20110028595 | FRICTION MATERIAL AND RESIN COMPOSITION FOR FRICTION MATERIAL - A friction material characterized by using a resin composition for friction materials, the resin composition containing, as a binder, an aromatic imide oligomer having an addition-reactive group at an end thereof. Also described is a resin composition for friction materials, containing: a powder of an aromatic imide oligomer having an addition-reactive group at an end thereof; at least one type of fiber selected from the group consisting of carbon fiber, aramid fiber, glass fiber, ceramic fiber, and metal fiber; and an inorganic filler. The friction material and a resin composition for friction materials have good formability and in which the binder itself has excellent heat resistance and mechanical properties, compared to a friction material using a phenolic resin as a binder. | 2011-02-03 |
20110028596 | RUBBER COMPOSITION FOR COATING A STEEL WIRE MATERIAL - A rubber composition is provided for coating a steel wire material having initial adhesion strength and water resistant adhesion strength with respect to a steel wire material at or above conventional levels, the rubber composition being compounded with a compound derived from a natural product. Specifically a rubber composition for coating a steel wire material is compounded with from 0.05 to 10 parts by weight of a salt compound per 100 parts by weight of a diene rubber, the salt compound including a dicarboxylic acid derived from a natural product and an amine of a decarboxylated amino acid derived from a natural product. | 2011-02-03 |
20110028597 | WATER-BASED CEMENT FOR PRODUCING TYRES - A water-based cement for producing tyres, having water as solvent, a cross-linkable unsaturated-chain polymer base, sulphur, a reinforcing filler, zinc oxide, accelerators, and an emulsifier of the general formula (I) | 2011-02-03 |
20110028598 | Rubber Composition with very low Zinc Content - The invention relates to a rubber composition based on at least one diene elastomer, containing less than 0.5 phe of zinc, phe signifying parts per hundred parts of elastomer, and based on at least:
| 2011-02-03 |
20110028599 | MANUFACTURING METHODS FOR THE PRODUCTION OF CARBON MATERIALS - The present application is generally directed to activated carbon materials and methods for making the same. The disclosed methods comprise rapidly freezing synthetically prepared polymer gel particles. The methods further comprise drying, pyrolyzing, and activating steps to obtain an activated carbon material of high porosity. The disclosed methods represent viable manufacturing processes for the preparation of activated carbon materials. | 2011-02-03 |
20110028600 | ANTIOXIDANT STABILIZED CROSSLINKED ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE FOR MEDICAL DEVICE APPLICATIONS - An antioxidant combined with UHMWPE prior to subjecting the UHMWPE to crosslinking irradiation. In one exemplary embodiment, the antioxidant is tocopherol. After the antioxidant is combined with the UHMWPE, the resulting blend may be formed into slabs, bar stock, and/or incorporated into a substrate, such as a metal, for example. The resulting product may then be subjected to crosslinking irradiation. In one exemplary embodiment, the UHMWPE blend is preheated prior to subjecting the same to crosslinking irradiation. Once irradiated, the UHMWPE blended product may be machined, packaged, and sterilized in accordance with conventional techniques. | 2011-02-03 |
20110028601 | AROMATIC POLYCARBONATE RESIN COMPOSITION AND A MOLDED ARTICLE THEREOF - The object of this invention is to provide a resin composition for giving molded articles that effectively block heat radiation from sunlight and are excellent in transparency, and molded articles thereof. | 2011-02-03 |
20110028602 | EPOXY-IMIDAZOLE CATALYSTS USEFUL FOR POWDER COATING APPLICATIONS - A process of forming a solid epoxy-imidazole catalyst, the process including: contacting an imidazole, an amine, and one or more epoxy resins, in the absence of added solvent, to form a solid epoxy-imidazole catalyst. In other aspects, embodiments disclosed herein relate to an epoxy-imidazole catalyst, as well as curable compositions, processes for forming curable compositions, and processes for forming a thermoset resin using the epoxy-imidazole catalyst formed in the absence of added solvent. | 2011-02-03 |
20110028603 | HYPERBRANCHED POLYMERS AND OLIGOMERS COMPRISING TERMINAL AMINO GROUPS AS CURING AGENTS FOR EPOXY RESINS - The invention relates to the use of hyperbranched polymers or oligomers comprising terminal primary and/or secondary amino groups as curing agents for epoxy resins. The invention further relates to a composition containing such polymers or oligomers, an uncured or only partially cured epoxy resin, and at least one optional curing agent for epoxy resins, as well as a cured epoxy resin that can be obtained by curing said components. The invention finally relates to a method for curing epoxy resins. In said method, an uncured or only partially cured epoxy resin is brought to a temperature of 5 to 150° C. or is exposed to microwave radiation along with at least one polymer or oligomer according to the definition above and at least one optional conventional curing agent for epoxy resins. | 2011-02-03 |
20110028604 | FLAME-RETARDANT, CURABLE MOULDING MATERIALS - The invention relates to a halogen-free flameproofing agent for curable moulding materials, the use of such flameproofing agents for the flame-retardant treatment of curable moulding materials, a process for the preparation of halogen-free, flame-retardant curable moulding materials, and halogen-free, flame-retardant curable moulding materials. | 2011-02-03 |
20110028605 | FILLED RESINS AND METHOD FOR MAKING FILLED RESINS - A method of making a filled resin includes providing functionalized particles; and combining and homogenously mixing the functionalized particles with an organic matrix in a vacuum kneader to provide the filled resin so that the functionalized particles comprise at least about 20% by weight of the filled resin. The step of providing functionalized particles can also include providing a feedstock of (i) untreated particles, (ii) a surface treatment agent reactive with the particles, and (iii) solvent, and directing the feedstock through a continuous reactor maintained at a temperature sufficient to react the particles with the surface treatment agent to provide the functionalized particles in less than about 4 hours; and directing the functionalized particles from the continuous reactor directly into the vacuum kneader. In another aspect, the a finished resin comprises at least about 20% by weight of functionalized particles in an organic matrix. | 2011-02-03 |
20110028606 | Glass Compositions And Fibers Made Therefrom - Embodiments of the present invention provides fiberizable glass compositions formed from batch compositions comprising significant amounts of one or more glassy minerals, including perlite and/or pumice. | 2011-02-03 |
20110028607 | Cement Compositions Comprising Stevia Retarders - Methods and compositions that include a method of cementing comprising providing a cement composition comprising water, a hydraulic cement, and an additive comprising at least one additive selected from the group consisting of a stevia retarder and inulin; placing the cement composition in a subterranean formation; and permitting the cement composition to set in the formation. | 2011-02-03 |
20110028608 | CELLULOSE SUSPENSION AND PROCESSES FOR ITS PRODUCTION - The present invention relates to cellulosic particles, a suspension of cellulosic particles and a process for the production of a suspension of cellulosic particles, whereby the cellulosic material is never dried between the dissolution of the cellulose and the disintegration of the suspended cellulose fibers. | 2011-02-03 |
20110028609 | Making Renewable Polyoxymethylene Compositions - Methods of making polyoxymethylene compositions having a polyoxymethylene polymer having a Mean Biobased Content of at least 20 percent determined with ASTM-D6866 method. | 2011-02-03 |
20110028610 | Latex Paints with Improved Fade Resistance - A paint comprising a latex base, organic pigment, and an aqueous solution resin solid with improved stability to atmospheric l pollutants. | 2011-02-03 |
20110028611 | SYNTHETIC RESIN COMPOSITION AND AUTOMOTIVE INTERIOR/EXTERIOR MATERIAL COMPRISING THE SAME - Disclosed are a synthetic resin composition having more excellent weather resistance and an automotive interior/exterior material comprising the synthetic resin composition. | 2011-02-03 |
20110028612 | SELF-STRATIFYING COATING - The present invention discloses a reactivity-based self-stratifying coating composition. The coating composition can include a polyol, silsesquioxane, a polyester polyol, and a crosslinker that form a mixture within a solvent. The polyol can be selected from a fluorinated polyether, a fluoroethylene-alkyl vinyl ether and/or a combination thereof. The silsesquioxane can be an epoxy functional silsesquioxane having a formula of (R) | 2011-02-03 |
20110028613 | FLAME-RETARDENT THERMOPLASTIC COMPOSITIONS - The invention relates to thermoplastic molding compositions comprising
| 2011-02-03 |
20110028614 | POLYAMIDE, POLYAMIDE COMPOSITION, AND METHOD FOR PRODUCING POLYAMIDE - The present invention relates to a polyamide obtainable by polymerizing an (a) dicarboxylic acid comprising at least 50 mol % of an alicyclic dicarboxylic acid and a (b) diamine comprising at least 50 mol % of a diamine having a substituent branched from a main chain. | 2011-02-03 |
20110028615 | FLAME-RETARDANT REINFORCED POLYCARBONATE COMPOSITIONS - A composition containing a polycarbonate, a polycarbonate-polysiloxane copolymer, an alicyclic hydrocarbon resin flow promoter, an inorganic filler, a flame retardant and an impact modifier. The compositions may include polycarbonate in an amount of 40% by weight or more of the combined weights of the polycarbonate, polycarbonate-polysiloxane copolymer, inorganic filler, flame retardant, flow promoter, and impact modifier compound wherein a molded sample of the thermoplastic composition is capable of achieving UL94 V0 rating at a thickness of 1.2 mm (±10%); wherein the polymer composition has a melt viscosity of 185 Pa·sec or less, when measured at 270° C. and 1500 sec | 2011-02-03 |